
Tuesday, July 30
FT News Briefing
00:00
Mylan's Struggles and Global Market Opportunities in Pharmaceuticals
This chapter explores Mylan's challenges in the U.S. generic drug market and its partnership with Opjion to tap into international markets like China. It contrasts rising branded drug prices with declining generic prices, indicating potential industry consolidation and previews earnings from major pharmaceutical and tech firms.
Play episode from 07:52
Transcript


